stars 1 stars 2 stars 3

Sinopia Biosciences, Inc. is a privately held biotechnology company advancing novel therapeutics using its proprietary LEADS® (LEarn And DiScover) drug discovery platform. Sinopia’s LEADS® platform integrates high-throughput omics data, AI/machine learning, and network analyses. Sinopia is advancing multiple first-in-class programs with high unmet need, including its lead program for Parkinson’s disease. Sinopia is headquartered at JLABS in San Diego, California.

Sinopia Biosciences Questions

The Sinopia Biosciences annual revenue was $4 million in 2026.

Iman Famili is the President and CEO of Sinopia Biosciences.

4 people are employed at Sinopia Biosciences.

Sinopia Biosciences is based in San Diego, California.

The NAICS codes for Sinopia Biosciences are [54171, 541714, 5417, 54, 541].

The SIC codes for Sinopia Biosciences are [87, 873].

Top Sinopia Biosciences Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users